Frequency and Mortality Associated with Hyperglycemia in Critically Ill Children

Sabeen Abid Khan1, Mohsina Noor Ibrahim2, Anwar-ul-Haq1

  • 1Department of Paediatrics, The Aga Khan University Hospital, Karachi.

Insights

Hyperglycemia is common in critically ill children and linked to higher mortality. Maintaining normal blood sugar levels in pediatric intensive care units (PICU) improves outcomes.

Area of Science:

  • Pediatric Critical Care Medicine
  • Endocrinology
  • Clinical Research

Background:

  • Hyperglycemia in critically ill children is a significant concern.
  • Understanding its prevalence and impact on mortality is crucial for improving patient outcomes.

Purpose of the Study:

  • To determine the frequency of hyperglycemia in critically ill children admitted to a pediatric intensive care unit (PICU).
  • To compare the mortality rates between hyperglycemic and normoglycemic critically ill children.

Main Methods:

  • A cross-sectional study was conducted in the PICU of the National Institute of Child Health (NICH), Karachi.
  • 150 critically ill children were enrolled; hyperglycemia was defined as fasting blood sugar >126 mg/dl within 48 hours of admission.
  • Patients were followed for 10 days to assess mortality associated with hyperglycemia.

Main Results:

  • Hyperglycemia was prevalent in 54.7% (82/150) of the critically ill children.
  • The overall mortality rate was 48.7% (73/150).
  • Mortality was significantly higher in the hyperglycemic group (57.3%) compared to the normoglycemic group (p=0.019).

Conclusions:

  • Stress-induced hyperglycemia in critically ill children is a marker of poor prognosis and high mortality.
  • Achieving normoglycemia is associated with better outcomes, including reduced mortality and shorter hospital stays.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
945
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K